0
Signin
countryflagUS

18889881171

AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

GlaxoSmithKline PLC ADR

Healthcare US GSK

40.91USD
0.05(0.12%)

Last update at 2024-04-25T20:10:00Z

Day Range

40.8041.11
LowHigh

52 Week Range

32.2237.83
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 5628.00M 5442.00M 6968.00M 6221.00M 4800.00M
Minority interest -665.00000M -711.00000M 6221.00M 6952.00M -109.00000M
Net income 4921.00M 4385.00M 5749.00M 4645.00M 3623.00M
Selling general administrative 8372.00M 10975.00M 11456.00M 11402.00M 9915.00M
Selling and marketing expenses - - - - -
Gross profit 19770.00M 22511.00M 22395.00M 21891.00M 20580.00M
Reconciled depreciation 2298.00M 2524.00M 2351.00M 2334.00M 1856.00M
Ebit 6433.00M 6201.00M 7783.00M 6961.00M 5595.00M
Ebitda 8805.00M 8786.00M 8484.00M 10129.00M 7358.00M
Depreciation and amortization 2372.00M 2585.00M 701.00M 3168.00M 1763.00M
Non operating income net other - - - 0.00000M 0.00000M
Operating income 6433.00M 6201.00M 7783.00M 6961.00M 5483.00M
Other operating expenses 22891.00M 27913.00M 26316.00M 26793.00M 25338.00M
Interest expense 879.00M 784.00M 892.00M 912.00M 798.00M
Tax provision 707.00M 346.00M 580.00M 953.00M 879.00M
Interest income 76.00M 723.00M 44.00M 708.00M 602.00M
Net interest income -803.00000M -756.00000M -848.00000M -840.00000M -728.00000M
Extraordinary items 10495.00M 1069.00M 1285.00M 0.00000M 125.00M
Non recurring - - - 0.00000M 0.00000M
Other items - - - 0.00000M 0.00000M
Income tax expense 707.00M 346.00M 580.00M 953.00M 754.00M
Total revenue 29324.00M 34114.00M 34099.00M 33754.00M 30821.00M
Total operating expenses 13337.00M 16310.00M 14612.00M 14930.00M 15097.00M
Cost of revenue 9554.00M 11603.00M 11704.00M 11863.00M 10241.00M
Total other income expense net -805.00000M -759.00000M -815.00000M -740.00000M -683.00000M
Discontinued operations 10495.00M 1069.00M 876.00M 876.00M 0.00000M
Net income from continuing ops 4921.00M 5096.00M 6388.00M 5268.00M 4046.00M
Net income applicable to common shares 14956.00M 4385.00M 5749.00M 4645.00M 3623.00M
Preferred stock and other adjustments - - - 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 60146.00M 79103.00M 80431.00M 79692.00M 58066.00M
Intangible assets 14318.00M 30079.00M 29824.00M 30955.00M 17202.00M
Earning assets - - - - -
Other current assets 7746.00M 8756.00M 8081.00M 8758.00M 7493.00M
Total liab 50050.00M 57761.00M 59623.00M 61335.00M 54394.00M
Total stockholder equity 10598.00M 15055.00M 14587.00M 11984.00M 4360.00M
Deferred long term liab - - - 0.00000M 0.00000M
Other current liab 2595.00M 958.00M 765.00M 755.00M 837.00M
Common stock 1347.00M 1347.00M 1346.00M 1346.00M 1345.00M
Capital stock 1347.00M 1347.00M 1346.00M 1346.00M 1345.00M
Retained earnings 4363.00M 7944.00M 6755.00M 5109.00M -2137.00000M
Other liab 10205.00M 13519.00M 14050.00M 13695.00M 11632.00M
Good will 7046.00M 10552.00M 10597.00M 10562.00M 5789.00M
Other assets 6852.00M 6894.00M 5261.00M 5094.00M 5527.00M
Cash 3723.00M 4274.00M 6292.00M 4707.00M 3874.00M
Cash and equivalents 3723.00M - - - -
Total current liabilities 22810.00M 23670.00M 22148.00M 24050.00M 22491.00M
Current deferred revenue - 1557.00M 1818.00M 1438.00M 1824.00M
Net debt 17264.00M 19899.00M 20858.00M 25801.00M 22190.00M
Short term debt 3952.00M 3601.00M 3725.00M 6918.00M 5793.00M
Short long term debt 3785.00M 3398.00M 3495.00M 6678.00M 5769.00M
Short long term debt total 20987.00M 24173.00M 27150.00M 30508.00M 26064.00M
Other stockholder equity 4888.00M 5764.00M 6486.00M 5529.00M 5152.00M
Property plant equipment 9620.00M 10672.00M 11006.00M 11314.00M 11058.00M
Total current assets 20769.00M 18674.00M 20247.00M 19491.00M 16927.00M
Long term investments - - - 64262.57M 29073.40M
Net tangible assets -10766.00000M -25576.00000M -25834.00000M -30112.00000M -19210.00000M
Short term investments 4154.00M 61.00M 78.00M 79.00M 84.00M
Net receivables 7053.00M -200.00000M 6862.00M 6441.00M 5946.00M
Long term debt 17035.00M 20572.00M 23425.00M 22580.00M 20227.00M
Inventory 5146.00M 5783.00M 5996.00M 5947.00M 5476.00M
Accounts payable 16263.00M 17554.00M 15840.00M 14939.00M 14037.00M
Total permanent equity - - - 0.00000M 0.00000M
Noncontrolling interest in consolidated entity - - - 0.00000M 0.00000M
Temporary equity redeemable noncontrolling interests - - - 0.00000M 0.00000M
Accumulated other comprehensive income - - - 0.00000M 0.00000M
Additional paid in capital - - - 0.00000M 0.00000M
Common stock total equity - - 1346.00M 0.00000M 0.00000M
Preferred stock total equity - - - 0.00000M 0.00000M
Retained earnings total equity - - - 0.00000M 0.00000M
Treasury stock - - - 0.00000M 0.00000M
Accumulated amortization - - - 0.00000M 0.00000M
Non currrent assets other 5348.00M 1755.00M 1124.00M 1202.00M 1729.00M
Deferred long term asset charges - - - 0.00000M 0.00000M
Non current assets total 39377.00M 60429.00M 60184.00M 60201.00M 41139.00M
Capital lease obligations 1008.00M 1015.00M 1117.00M 1250.00M 68.00M
Long term debt total 17035.00M 20572.00M 23425.00M 23590.00M 20271.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -8772.00000M 334.00M 2161.00M -5354.00000M -1553.00000M
Change to liabilities 494.00M 284.00M 225.00M 263.00M 131.00M
Total cashflows from investing activities -8772.00000M -1777.00000M 2161.00M -5354.00000M -1553.00000M
Net borrowings -4824.00000M -2210.00000M -4234.00000M 3515.00M 8124.00M
Total cash from financing activities 823.00M -7589.00000M -10132.00000M -1840.00000M -6389.00000M
Change to operating activities -1425.00000M 1260.00M -159.00000M -160.00000M 18.00M
Net income 4921.00M 5096.00M 6388.00M 5268.00M 4046.00M
Change in cash -394.00000M -1443.00000M 431.00M 744.00M 487.00M
Begin period cash flow 3819.00M 5262.00M 4831.00M 4087.00M 3600.00M
End period cash flow 3425.00M 3819.00M 5262.00M 4831.00M 4087.00M
Total cash from operating activities 7403.00M 7952.00M 8441.00M 8020.00M 8421.00M
Issuance of capital stock 25.00M 21.00M 29.00M 51.00M 74.00M
Depreciation 2298.00M 2524.00M 624.00M 2996.00M 1763.00M
Other cashflows from investing activities -6514.00000M 36.00M 70.00M 89.00M 111.00M
Dividends paid -3467.00000M -3999.00000M -3977.00000M -3953.00000M 3927.00M
Change to inventory -269.00000M 25.00M 119.00M 300.00M 51.00M
Change to account receivables -158.00000M -782.00000M -224.00000M -953.80435M -7979.83998M
Sale purchase of stock 25.00M -1643.00000M 999.00M 10284.00M 8774.00M
Other cashflows from financing activities 8887.00M 27.00M 122.00M -194.00000M -9324.00000M
Change to netincome -8342.00000M 105.00M 380.00M 670.00M 3171.00M
Capital expenditures 2258.00M 2931.00M 2239.00M 2163.00M 1796.00M
Change receivables - - - 0.00000M 0.00000M
Cash flows other operating - - - 0.00000M 0.00000M
Exchange rate changes - - - 0.00000M 0.00000M
Cash and cash equivalents changes - - - 0.00000M 0.00000M
Change in working capital 271.00M -473.00000M 120.00M 531.00M -247.00000M
Stock based compensation 346.00M 367.00M 381.00M 365.00M 360.00M
Other non cash items -433.00000M 756.00M 848.00M 814.00M 717.00M
Free cash flow 5145.00M 5021.00M 6202.00M 5857.00M 6625.00M

Fundamentals

  • Previous Close 40.86
  • Market Cap75048.04M
  • Volume3015243
  • P/E Ratio9.73
  • Dividend Yield3.85%
  • EBITDA9186.00M
  • Revenue TTM29652.00M
  • Revenue Per Share TTM14.66
  • Gross Profit TTM 19917.00M
  • Diluted EPS TTM3.75

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - General

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GSK
GlaxoSmithKline PLC ADR		 0.05 0.12% 40.91 9.73 9.15 2.53 4.51 3.14 9.68
LLY
Eli Lilly and Company		 -7.33 1.00% 724.87 103.14 46.73 16.88 48.24 17.43 69.11
JNJ
Johnson & Johnson		 -1.71 1.15% 146.82 29.17 14.33 3.74 5.18 3.80 15.22
ABBV
AbbVie Inc		 -0.51 0.30% 167.29 42.38 13.68 4.88 22.14 5.72 31.93
MRK
Merck & Company Inc		 3.70 2.91% 130.70 59.83 12.33 4.50 6.47 4.94 23.79

Reports Covered

Stock Research & News

View All

Profile

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

GlaxoSmithKline PLC ADR

980 Great West Road, Brentford, United Kingdom, TW8 9GS

Key Executives

Name Title Year Born
Ms. Emma Natasha Walmsley CEO & Director 1970
Mr. Iain James Mackay CFO & Exec. Director 1962
Ms. Julie Brown Chief Financial Officer 1962
Ms. Shobie Ramakrishnan Chief Digital & Technology Officer NA
Mr. Tony Wood Chief Scientific Officer NA
Ms. Sarah Elton-Farr Head of Investor Relations NA
Mr. James Ford Sr. VP & Group Gen. Counsel of Legal & Compliance NA
Ms. Sally Jackson Sr. VP of Global Communications & CEO Office NA
Ms. Diana Conrad Chief People Officer NA
Mr. David Simon Redfern Chief Strategy Officer 1966

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).